Ignite Creation Date:
2024-05-05 @ 11:13 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01286987
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2011-01-26
Brief Title:
Study of Talazoparib a PARP Inhibitor in Patients With Advanced or Recurrent Solid Tumors
Sponsor:
Pfizer
Organization:
Pfizer